معرفی
Carmine Gentile is an Associate Professor at the University of Technology Sydney (UTS) within the School of Biomedical Engineering, Faculty of Engineering and IT, and leads the Cardiovascular Regeneration Group at the Heart Research Institute (HRI). His work bridges engineering, cardiology, and oncology through innovative bioprinting and stem cell approaches.
Education:
- BSc/MSc in Pharmaceutical Chemistry and Technologies, University of Pisa, Italy
- PharmD, University of Pisa, Italy
- PhD in Biomedical Sciences (Cardiovascular), Medical University of South Carolina, USA (funded by American Heart Association Fellowship)
Research Interests: Internationally recognized for pioneering 3D bioprinting of human heart tissues using patient-derived "mini-hearts" as bioink, his work targets myocardial infarction and heart failure. Recent focus includes CardioOncology—developing personalized predictive tools for cancer therapy-induced cardiac toxicity using stem cell organoids and identifying cardioprotective drugs that preserve cancer treatment efficacy.
Scientific Awards:
- American Heart Association Fellowship
- Fellow of the American Heart Association (FAHA)
Advising and Grants: Leads multidisciplinary teams of scientists, clinicians, and industry partners to accelerate bench-to-bedside translation. Secured sustained funding since 2013 for cardiovascular regeneration research, including collaborations with Harvard Medical School (2016 Visiting Research Fellowship) and Concord Hospital. Mentors researchers in developing clinically translatable cardiac models.
Labs and Teams: Founded the Cardiovascular Regeneration Group at HRI/UTS and co-established the world's first CardioOncology Centre with Professor Julie McMullen, integrating expertise from HRI, UTS, and Concord Hospital to address chemotherapy-induced heart damage through stem cell-based diagnostics and therapeutics.
